Purchase Order 36C24623P0466
Award Date
1/10/23
Potential Completion Date
1/31/24
Potential Value
$185K
Federal Agency
Veterans Integrated Service Network 6
Awardee
Accredo Health Group, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bartlett, TN 38134, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal purchase order awarded by the U.S. Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a specialty pharmacy services provider, for the supply of TYVASCO MEDICATION 0.6MG REFILL KITS. The $14,693.72 firm fixed-price contract has an ultimate completion date of October 9, 2024. Accredo, a subsidiary of Express Scripts, is a prime contractor that specializes in distributing complex and costly drugs used to treat chronic conditions, particularly in support of the VA's...
The U.S. Department of Veterans Affairs (VA) awarded a $81,342.18 firm fixed-price purchase order contract to Accredo Health Group, Inc., a for-profit pharmacy benefit management company, to provide the specialty pharmaceutical TYVASO. The contract, which does not have a set-aside designation, is to support the VA's Veterans Integrated Service Network 21 (VISN 21) and has an ultimate completion date of September 30, 2022. Accredo Health Group, Inc. is a key distributor of complex and...
This is a $93,341.96 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company. The contract is for the specialty pharmaceutical Tyvaso, which is used to treat pulmonary arterial hypertension. This contract is part of Accredo Health Group's ongoing work supporting the VA's Veterans Integrated Service Network (VISN) 21 with the distribution of specialty medications. The...
This is a firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company. The contract, valued at $94,899.21, is for the delivery of the drug Tyvaso, which is used to treat pulmonary arterial hypertension. The contract is not associated with a larger contract vehicle and does not have a set-aside designation. Accredo Health Group, Inc. is the prime contractor and there are no major...
This is a $81,632.25 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit subsidiary of Express Scripts that specializes in providing specialty pharmaceutical services. The contract is for the delivery of the medication Tyvaso, which is used to treat pulmonary arterial hypertension. The contract has no set-aside designation and was awarded on April 6, 2021, with a completion date of September 30, 2021....
The Department of Veterans Affairs Veterans Health Administration awarded a $13,557 purchase order to Accredo Health Group, Inc. to deliver TYVASO in Palo Alto, California from January 18, 2023 through April 18, 2023. As a prime contractor supporting VA's Veterans Integrated Service Network 21, Accredo Health Group will provide the pulmonary arterial hypertension medication on a firm fixed price basis. No subcontractors or set aside designations were indicated. This purchase order was issued...
Accredo Health Group, Inc. was awarded a firm fixed price purchase order without set-aside by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21. The order is for the delivery of TYVASO to the Palo Alto, California location, with a potential value of $47,594.01 and completion by May 22, 2023. As a prime contractor supporting the VA through its national pharmaceutical contracts, Accredo Health Group will distribute this specialized pulmonary...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 6 awarded a $14,221.32 delivery order to United Therapeutics Corp under the Pharmaceuticals and Drugs (FSS-61-IB) GSA Schedule. The firm fixed price order is for TYVASO REFILL KITS to be delivered to a location in Bartlett, Tennessee by March 17, 2023. No set-aside designation was used for this order placed against the larger Pharmaceuticals and Drugs vehicle to supply refill kits for the...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 6 (VA-VHA VISN 6) awarded a $149,388 firm fixed price purchase order to Accredo Health Group, Inc. of Bartlett, Tennessee for the delivery of Oxiviate Ophthalmic Solution. As a prime contractor supporting VA-VHA pharmaceutical needs, Accredo will provide the specified eye medication to VA medical facilities in the region under the terms of this one month contract running from August 18th to...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded a $14,221.32 firm fixed price purchase order to Accredo Health Group, Inc. for the delivery of treprostinil 0.6mg/ml solution for inhalation. Performance will take place in Bartlett, Tennessee over the period of October 5, 2023 through October 31, 2023. The award was made using the Federal Supply Schedule, which provides standard drugs, pharmaceuticals, and medical supplies to meet...